Systemic Antifungal Agents and Clinical Application.
- Author:
Jae Bum JUN
1
;
Sang Ho CHOI
;
Ji So RYU
;
Jun Hee WOO
Author Information
1. Division of Infectious Disease, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea. junheewoo@amc.seoul.kr r
- Publication Type:Original Article
- Keywords:
Liposomal amphotericin B;
Voriconazole;
Caspofungin
- MeSH:
Amphotericin B;
Antifungal Agents*;
Echinocandins;
Incidence;
Organ Transplantation;
Transplants;
Triazoles
- From:Korean Journal of Medical Mycology
2005;10(1):1-10
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In the past, even two decades ago, it was not easy for the physicians to diagnose the systemic fungal infection especially in immuno-compromised host. However, as malignant neoplasm and organ transplantation increased, the incidence of fungal infection became heightened. Also the development of newer technique of microbiology and computerized imaging methods made it relatively easy to diagnose the fungal infection. Several new antifungal agents developed recently. It is necessary for us to prescribe the antifungal agents optimally. We summarized amphotericin B lipid formulations, newer triazoles, echinocandins.
